Simons Trading Research

UG Healthcare - Put on This Glove; Initiate Coverage With ADD

simonsg
Publish date: Mon, 22 Jun 2020, 11:34 PM
simonsg
0 3,868
Simons Stock Trading Research Compilation
  • We believe UG Healthcare’s manufacturing cum distribution model allows for higher ASP hike potential amid strong glove demand due to the Covid-19 outbreak.
  • We expect UG Healthcare to benefit from
    1. higher ASPs,
    2. stronger volume, and
    3. higher margins, and forecast net profit to quadruple in FY20F.
  • We believe valuation is attractive at 8.7x CY21F P/E. Initiate with an ADD rating and Target Price of S$1.36, based on 15x CY21F P/E (40% discount to peers).

UG Healthcare - Company Background

  • Established in 1989, UG Healthcare (SGX:41A) is a Malaysia-based glove manufacturer with its own global downstream distribution network that markets and sells disposable glove products under its proprietary “Unigloves” brand.

UG Healthcare - Valuation & Recommendation

Under-appreciated stock in the glove sector; initiate with ADD rating and Target Price of S$1.36

Summary of analysis to be updated. Meanwhile, click on 'view full report' button below to see attached 23-page PDF report for complete analysis on UG Healthcare (SGX:41A).

Source: CGS-CIMB Research - 22 Jun 2020

Related Stocks
Market Buzz
Discussions
Be the first to like this. Showing 8 of 8 comments

bryan2003

Another glove counter (Rubberex) in Malaysia has released QR report. It made approximate SGD 3M from January till March 2020. It's yearly capacity is only 1B++ and if it can make such profit, there is no reason UG Healthcare will make lesser than it since UG Healthcare is OBM with own distribution center in UK, German, China, Nigeria and Brazil. Also, these distribution centers are also selling other product such as mask, gown, hand santinizer, thermometer etc. All these are high demand during this pandemic.

UG healthcare is still a counter which worth to have a look...

2020-06-29 22:48

bryan2003

As mentioned earlier, UG Healthcare has same business model as Supermax. Both of these company are OBM and have their own distribution center at different countries.

Below link is an article produced by a famous investor in Malaysia. We can use the similar method to apply on UG Healthcare.

https://klse.i3investor.com/blogs/koonyewyinblog/2020-07-01-story-h150...

There is very high possibility that UG has very good first half result as the share price going up non stop.

Coincidently that all their distribution centers are located at the countries that badly affected by Covid-19 such as Brazil, US, German and Nigeria.

If we search deeper, the direction of the company seems like toward a one stop solution model. If we google Uniglove Germany or Uniglove Nigeria, we can see that these distribution centers are selling glove, mask, disinfection under it's own brand - Uniglove. Please read the links below.

https://unigloves.de/30yearsEN/#0...

https://www.unimedicalhealthcare.com/...

Not to neglected that Uniglove UK is also selling antimicrobial glove which is high demand for this pandemic as this glove can kill gems. So far in the market, only Hartalega which listed in Bursa Malaysia produces antimicrobial glove in large scale. In short, UG healthcare will be benefitted as UK is one of the country that badly impacted by Covid-19.

In conclusion, UG overall business will be benefitted as many of the product they are selling are high demand during this pandemic.

2020-07-01 22:38

bryan2003

Flip through the AR again, I realized that the founder / BOD and their family members are actually holding approximate 73.64% of the issued shares instead of what i had mentioned earlier 60%++. Hence, the liquidity in the market is less. Possible that the BOD will bonus issue or share split in the coming QR report to increase the liquidity in the market as well as expand their business. With all these, the share price may not U turn at all.

Unable to upload picture here but you guys can see the details from below link.

https://www.investingnote.com/stocks/SGX:41A#/all

2020-07-02 07:13

bryan2003

hi guys,

just checked online the selling price of Uniglove's antimicrobial glove, the selling price is crazy. It is close to USD 250 per 1000 pcs. Please refer to the link below.

https://www.safetygloves.co.uk/unigloves-fortified-gf001-antimicrobial-blue-nitrile-gloves.html

Even though this selling price is from the dealer or distributor. But let's assume Uniglove is selling at USD 150 to the distributor. What kind of profit they are making??

2020-07-06 00:16

bryan2003

The famous investor cum tychoon in Malaysia just posted a blog as below link.

https://klse.i3investor.com/blogs/koonyewyinblog/

So what about UG Healthcare which is OBM (Unigloves) and also have distribution centers at US, UK, German, Brazil and Nigeria? Besides glove, there are selling PPE and other healthcare products which are high demand during pandemic.

2020-07-08 13:45

bryan2003

https://klse.i3investor.com/blogs/koonyewyinblog/

If we apply to same concept to UG since UG' s business model is the same as Supermax, so what is the price it deserves?

2020-07-09 05:54

bryan2003

Is the situation of UG similar to what have mentioned in the link below?

https://klse.i3investor.com/blogs/koonyewyinblog/

Even the movement of the share price????

Happy weekend..

2020-07-10 16:31

Post a Comment